moclobemide and Pain
moclobemide has been researched along with Pain in 4 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "This trial aimed to study moclobemide, a reversible, Type-A selective monoamine oxidase inhibitor, in patients with chronic neuropathic pain." | 9.08 | Moclobemide in chronic neuropathic pain: preliminary case reports. ( Busch, AF; Fawcett, JP; Jones, D; Menkes, DB, 1995) |
| "This trial aimed to study moclobemide, a reversible, Type-A selective monoamine oxidase inhibitor, in patients with chronic neuropathic pain." | 5.08 | Moclobemide in chronic neuropathic pain: preliminary case reports. ( Busch, AF; Fawcett, JP; Jones, D; Menkes, DB, 1995) |
| " The efficacies between the two dosing regimens as determined by the HAM-D score and from the CGI were found not to differ significantly." | 2.68 | A comparison of the efficacy and tolerability of moclobemide given as a single daily dose or in three divided doses per day for the treatment of patients with a major depressive episode (DSM-III-R) ( Caracatsanis, A; Collier, J; Collins, C; Cramer, D; Edwards, R; Fox, K; Newburn, G; Reeves, J; Thomas, H, 1995) |
| " While clinical aspects will be presented in a subsequent review, this article focuses primarily on moclobemide's evolution, pharmacodynamic and pharmacokinetic properties." | 2.41 | Moclobemide: evolution, pharmacodynamic, and pharmacokinetic properties. ( Bonnet, U, 2002) |
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bonnet, U | 1 |
| Menkes, DB | 1 |
| Fawcett, JP | 1 |
| Busch, AF | 1 |
| Jones, D | 1 |
| Newburn, G | 1 |
| Edwards, R | 1 |
| Thomas, H | 1 |
| Collier, J | 1 |
| Fox, K | 1 |
| Collins, C | 1 |
| Cramer, D | 1 |
| Reeves, J | 1 |
| Caracatsanis, A | 1 |
| Coquoz, D | 1 |
| Porchet, HC | 1 |
| Dayer, P | 1 |
Reviews
1 review available for moclobemide and Pain
| Article | Year |
|---|---|
Moclobemide: evolution, pharmacodynamic, and pharmacokinetic properties.
Topics: Animals; Antidepressive Agents; Anxiety; Cognition Disorders; Depression; Disease Models, Animal; Dr | 2002 |
Trials
3 trials available for moclobemide and Pain
| Article | Year |
|---|---|
Moclobemide in chronic neuropathic pain: preliminary case reports.
Topics: Adult; Aged; Analgesics; Benzamides; Chronic Disease; Female; Humans; Male; Middle Aged; Moclobemide | 1995 |
A comparison of the efficacy and tolerability of moclobemide given as a single daily dose or in three divided doses per day for the treatment of patients with a major depressive episode (DSM-III-R)
Topics: Adult; Antidepressive Agents; Anxiety; Benzamides; Depressive Disorder; Double-Blind Method; Female; | 1995 |
[Central analgesic effects of antidepressant drugs with various mechanisms of action: desipramine, fluvoxamine and moclobemide].
Topics: Analgesics; Antidepressive Agents; Benzamides; Desipramine; Double-Blind Method; Electric Stimulatio | 1991 |